Want to see HK:1526 full AI Analyst Report?
Top Page
Rici Healthcare Holdings Ltd.
(1526)
Select Model
Select Model
Rating:68Neutral
Price Target:
HK$0.88
▲(8.27% Upside)
Action:Downgraded
Date:08/21/26
The score is driven primarily by solid financial performance (healthy margins and strong cash generation) and very attractive valuation (low P/E and dividend). These positives are meaningfully offset by weak technicals, with the stock in a downtrend and bearish/oversold momentum signals.
Positive Factors
Strong Profitability
Healthy gross, operating, and net margins indicate that the company converts revenue into profit effectively. This profitability provides internal funding for operations and investment, supports resilience across the care-facilities cycle, and can strengthen competitive positioning over the next several quarters.
Negative Factors
Meaningful Leverage
Although leverage has improved, the sizable debt load still reduces balance-sheet flexibility. If operating conditions soften, debt service and refinancing needs could compete with investment or shareholder returns, making the company more sensitive to sustained pressure on earnings and cash flow.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Profitability
Healthy gross, operating, and net margins indicate that the company converts revenue into profit effectively. This profitability provides internal funding for operations and investment, supports resilience across the care-facilities cycle, and can strengthen competitive positioning over the next several quarters.
Read all positive factors
Rici Healthcare Holdings Ltd. (1526) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.29B
Dividend Yield2.41%
Average Volume (3M)178.50K
Price to Earnings (P/E)3.8
Beta (1Y)0.20
Revenue Growth1.25%
EPS Growth12.60%
CountryHK
Employees8,523
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.18
Shares Outstanding1,590,324,000
10 Day Avg. Volume98,900
30 Day Avg. Volume178,500
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.97
Price to Sales (P/S)0.57
P/FCF Ratio2.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rici Healthcare Holdings Ltd. Business Overview & Revenue Model
Company Description
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical exa...
How the Company Makes Money
null...
Rici Healthcare Holdings Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
64
Positive
Cash Flow
74
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.80B | 2.92B | 2.99B | 2.38B | 2.38B |
| Gross Profit | 1.21B | 1.17B | 1.25B | 927.20M | 975.22M |
| EBITDA | 883.88M | 798.69M | 1.07B | 572.61M | 682.80M |
| Net Income | 307.13M | 297.32M | 363.80M | 290.79M | 181.55M |
Balance Sheet | |||||
| Total Assets | 4.88B | 4.86B | 4.64B | 4.57B | 4.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.12B | 811.21M | 720.14M | 784.36M |
| Total Debt | 2.01B | 2.30B | 2.27B | 2.30B | 2.74B |
| Total Liabilities | 3.16B | 3.48B | 3.52B | 3.66B | 3.95B |
| Stockholders Equity | 1.65B | 1.35B | 1.13B | 953.92M | 677.50M |
Cash Flow | |||||
| Free Cash Flow | 561.55M | 584.35M | 487.07M | 396.33M | 356.41M |
| Operating Cash Flow | 719.39M | 790.58M | 826.29M | 706.37M | 681.07M |
| Investing Cash Flow | -301.48M | -140.02M | -147.00M | -273.99M | -269.13M |
| Financing Cash Flow | -388.92M | -351.23M | -592.72M | -495.23M | -193.99M |
Rici Healthcare Holdings Ltd. Technical Analysis
Negative
0.81
Price Trends
1.00
Negative
0.88
Negative
0.91
Negative
Market Momentum
-0.05
Negative
39.34
Neutral
57.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Negative. The current price of 0.81 is below the 20-day moving average (MA) of 0.86, below the 50-day MA of 1.00, and below the 200-day MA of 0.91, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 39.34 is Neutral, neither overbought nor oversold. The STOCH value of 57.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1526.
Rici Healthcare Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.77B | 8.89 | 6.97% | 9.69% | 3.85% | -1.23% | |
68 Neutral | HK$1.29B | 3.76 | 17.86% | 2.41% | 1.25% | 12.60% | |
67 Neutral | HK$1.01B | 9.74 | 5.57% | 2.44% | 4.75% | ― | |
66 Neutral | HK$735.48M | 298.70 | 0.20% | 1.92% | 20.54% | -96.74% | |
56 Neutral | HK$1.20B | 82.86 | 0.48% | 1.03% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | 23.49 | 5.59% | ― | ― | ― |
* Healthcare Sector Average
HK:1526
Rici Healthcare Holdings Ltd.
0.83
-0.17
-16.75%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.06
4.00%
HK:1846
EuroEyes International Eye Clinic Limited
2.30
-0.69
-23.18%
HK:2219
Chaoju Eye Care Holdings Ltd.
2.50
0.01
0.48%
HK:3309
C-MER Eye Care Holdings Limited
0.82
-1.08
-56.84%
HK:3886
Town Health International Medical Group Ltd.
0.17
-0.08
-32.30%
Rici Healthcare Holdings Ltd. Corporate Events
Rici Healthcare Moves to Replace Auditor BDO With Rongcheng After Fee Review
Aug 28, 2026
Rici Healthcare Holdings Ltd. has announced a proposed change of auditor, with BDO resigning as the company’s auditor following the passing of a relevant resolution at an extraordinary general meeting. Subject to shareholder approval, the bo...
Rici Healthcare Posts Softer Interim Results and Halts Interim Dividend
Aug 28, 2026
Rici Healthcare Holdings Ltd., a Cayman Islands–incorporated healthcare group listed in Hong Kong, operates through subsidiaries to deliver medical and healthcare services across mainland China, positioning itself within the growing Chinese ...
Rici Healthcare Sets Board Meeting to Review Interim Results and Dividend
Aug 13, 2026
Rici Healthcare Holdings Ltd. has scheduled a board meeting for August 28, 2026, to review and approve the interim results for the six months ended June 30, 2026. The board will also consider the potential declaration of an interim dividend, a dec...
Rici Healthcare Moves to Replace Auditor to Cut Costs
Jul 27, 2026
Rici Healthcare Holdings Ltd. has proposed changing its auditor, seeking shareholder approval to appoint Rongcheng Hong Kong CPA Limited after the resignation of BDO Limited. The move follows a failure to reach consensus on the audit fee for the 2...
Rici Healthcare Clarifies Full Board Attendance at 2026 AGM
Jun 18, 2026
Rici Healthcare Holdings has issued a supplemental announcement regarding its annual general meeting held on June 17, 2026, clarifying that all directors attended either in person or via electronic means. The company emphasized that, aside from th...
Rici Healthcare Shareholders Approve All AGM Resolutions, Back Board Mandates
Jun 17, 2026
Rici Healthcare Holdings Ltd., a Hong Kong-listed Chinese healthcare services provider, reported that all resolutions at its 17 June 2026 annual general meeting in Shanghai were approved by shareholders via poll voting. The meeting covered adoptio...
Rici Healthcare Launches HK$100 Million Share Buyback to Signal Confidence and Support Valuation
Jun 17, 2026
Rici Healthcare Holdings has received shareholder approval to repurchase up to 10% of its issued shares and the board has authorised a buyback of up to HK$100 million using its own funds. The repurchased shares will be held as treasury stock, with...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.